Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

ASX 200 (XJO) To Open Higher, 3 ASX Shares To Watch

The ASX 200 (INDEXASX: XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 0.36% on Thursday.

Australian Dollar ($A) (AUDUSD): 70.62US cents

Dow Jones (DJI): up 0.01%

Oil (WTI): $US55.76 per barrel

Gold: $US1,444 per ounce

ASX Sharemarket News

In ASX sharemarket news, major ASX bank National Australia Bank Ltd. (ASX: NAB) has chosen who its new CEO will be.

NAB has announced that Ross McEwan has been appointed as the new CEO of the bank.

Mr McEwan had been CEO of Royal Bank of Scotland since 2013 and had led the organisation through significant change and recovery according to NAB.

NAB Chairman-elect Philip Chronican said: “Ross McEwan is the ideal leader for NAB as we seek to transform our operations and culture firmly around leading customer service, experience and products.”

[ls_content_block id=”15758″ para=”paragraphs”]

Sydney Airport Holdings Pty Ltd (ASX: SYD) has released its traffic numbers for June 2019.

Domestic passengers fell by 1.6% to 2.1 million whilst international passengers grew by 1.1% to 1.3 million, meaning that total passengers fell by 0.5% to 3.4 million.

Sydney Airport CEO Geoff Culbert said: “Sydney’s top five fastest growing passenger groups over the month were Vietnam, Taiwan, Japan, USA and India, all recording double digit growth compared to June 2018.”

Popular Stories:

Ellex Medical Lasers Ltd (ASX: ELX) has appointed an interim CEO and revealed a trading update.

Ms Maria Maieli has been appointed as the interim CEO, effective today, with Mr Ged Wallace informing the Board of his decision to resign.

In FY19 the preliminary results show that group sales were up 3% to $82 million. Excluding restructuring expenses, the underlying EBITDA (click here to learn what EBITDA means) loss is projected to be $0.7 million to $0.8 million.

[ls_content_block id=”14946″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content